Bookmark and Share
Envelope surface glycoprotein gp160, precurso.. [gi:9629363] - Target BioActivity Data
Also known as: Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1].
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(4327)
 
 
BioAssay Types:
Screening(4276)
 
 
Confirmatory(51)
 
 
BioActivity Types:
IC50(51)
 
 
Substance Types:
Chemical(4327)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 6    Data Row: 4327   Total Pages: 217   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID87348582]
[CID1943710]
IC50 1.546Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
2
[SID87348582]
[CID1943710]
IC50 1.723Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PG126, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651939, Type: confirmatory]
View
3
[SID124755607]
[CID53301435]
IC50 2.051Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PG126, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651939, Type: confirmatory]
View
4
[SID124755607]
[CID53301435]
IC50 2.138Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
5
[SID14742160]
[CID2014844]
IC50 2.251Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PG126, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651939, Type: confirmatory]
View
6
[SID14742160]
[CID2014844]
IC50 2.358Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
7
[SID17432014]
[CID2185557]
IC50 2.417Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
8
[SID17432014]
[CID2185557]
IC50 2.448Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PG126, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651939, Type: confirmatory]
View
9
[SID87337560]
[CID692203]
IC50 2.499Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
10
[SID22402140]
[CID2137373]
IC50 2.857Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
11
[SID124755607]
[CID53301435]
IC50 2.873TRFRET-based biochemical high throughput dose response assay for small molecules that bind to the HIV-1-gp120 binding antibody, PG9 [AID651848, Type: confirmatory]
View
12
[SID87348582]
[CID1943710]
IC50 3.284TRFRET-based biochemical high throughput dose response assay for small molecules that bind to the HIV-1-gp120 binding antibody, PG9 [AID651848, Type: confirmatory]
View
13
[SID14742160]
[CID2014844]
IC50 3.425TRFRET-based biochemical high throughput dose response assay for small molecules that bind to the HIV-1-gp120 binding antibody, PG9 [AID651848, Type: confirmatory]
View
14
[SID14739343]
[CID2197541]
IC50 3.442Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
15
[SID4241822]
[CID3236746]
IC50 3.553Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
16
[SID17510258]
[CID1191851]
IC50 3.629Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PG126, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651939, Type: confirmatory]
View
17
[SID17411505]
[CID1472976]
IC50 3.662Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
18
[SID17510258]
[CID1191851]
IC50 3.696Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View
19
[SID22402140]
[CID2137373]
IC50 3.746Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PG126, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651939, Type: confirmatory]
View
20
[SID14738001]
[CID9551239]
IC50 3.881Counterscreen for discovery of small molecules that bind to the HIV-1-gp120 binding antibody, PG9: TR-FRET-based biochemical high throughput dose response assay to identify small molecules that bind to the control antibody, PGV04, which binds to a distinct site on the HIV envelope different from the PG9 binding site [AID651937, Type: confirmatory]
View